PDF
The Bayh-Dole Act
![](/sites/default/files/images/toolkit/The-Bayh-Dole-Act-04162020-1_page-1.jpg)
The Bayh-Dole Act
Learn about how the Bayh-Dole Act benefits the U.S. economy, consumers & patients.
VIEW DETAILS
![](/sites/default/files/images/toolkit/IGP3_1.jpg)
Bayh-Dole Act has Bolstered U.S. Economic Output
The Bayh-Dole Act has bolstered U.S. economic output by $1.3 trillion, supported 4.2 million jobs, and helped lead to more than 11,000 start-up companies.
VIEW DETAILS
![](/sites/default/files/images/toolkit/IGP3_2.jpg)
Global Industry R&D vs. NIH Budget
The Bayh-Dole Act encourages private-sector investment needed to turn government-funded basic biomedical research into tested and approved products and ensures royalties for universities to further advance basic research and education.
VIEW DETAILS
![](/sites/default/files/images/toolkit/IGP3-2-650x840.jpg)
Preserving a Unique Public-Private Partnership for Future Innovation
The Bayh-Dole Act benefits the U.S. economy, taxpayers, consumers and patients, but certain activists are trying to undermine the law. Some want to force the government to “march-in” by arbitrarily tying prescription drugs prices in the U.S. to prices set in foreign countries.
VIEW DETAILS